TOVX

Theriva Biologics Inc

$0.25

-0.01 (-2.93%)

Analyst Overview

Target Price:

Date: 29.08.2026

$2.50

(+919.99%)

Strong Buy: 0

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Description:

Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. The company is headquartered in Rockville, Maryland.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850

Fiscal year end:

December

Market capitalization:

$11.6 Million

EBITDA:

-$12 Million

PERatio:

0.175

EPS:

1.44

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

1.118

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

29-07-2016: $15,312.50 and 31-07-2026: $0.21